S&e Bio

Developer of cell therapies for neurological disorders

placeSeoul, Seoul, South Korea calendar_todayFounded 2019 language snebio.com

Innovation

14 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 145 times.

YearFilings
20224
20235
20245
202511

Investor mix

4 investors on record; lead investors include KB Investment, Korea Investment Holdings, Company K Partners, LSK investment.

Investor typeCountShare
Venture capital375%
Bank & private debt125%
Coming soon